Wie Biotech-Aktien auf Donald Trump reagieren
26 January 2017
Download
Trump lässt Pharmaanleger erschauern
12 January 2017
Download
DePuy Synthes Acquires Interventional Spine Expandable Cage Technology to Accelerate Growth in Spine
3 January 2017
Download
ARMO BioSciences? Immunotherapy AM0010 Receives Orphan Drug and Fast Track Designations from the U.S. FDA for the Treatment of Pancreatic Cancer
14 November 2016
Download
Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals
1 November 2016
Download
Curetis Announces Positive Top Line Data from U.S. FDA Trial
25 October 2016
Download
Gynesonics completes enrollment in SONATA FDA trial for treatment of uterine fibroids
18 October 2016
Download
ObsEva starts Phase IIb EDELWEISS study in endometriosis
11 October 2016
Download
Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares
5 October 2016
Download
Andreas Wicki, CEO HBM Healthcare Investments, im Interview
12 September 2016
Download
Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016
31 August 2016
Download
Paratek Initiates Phase 3 Study of Oral-Only Omadacycline in ABSSSI
15 August 2016
Download
Im Schweizer Biotech-Segment ist viel Feingefühl gefragt
3 August 2016
Download
ObsEva initiates Phase 1 for OBE022 in Preterm Labor
28 July 2016
Download
Cell Medica Acquires Delenex Therapeutics
12 July 2016
Download
ObsEva Receives FDA Clearance to Initiate Phase 2b Study of OBE2109 in Endometriosis
6 July 2016
Download
AnaptysBio Initiates Multiple Ascending Dose Cohorts in ANB020 Phase 1 Clinical Trial
6 July 2016
Download
Advanced Accelerator Applications Announces FDA Priority Review for Lutathera
27 June 2016
Download
Paratek Announces that Omadacycline Met All Primary and Secondary Efficacy Outcomes Designated by FDA and EMA in a Phase 3 Study in Acute Bacterial Skin Infections
16 June 2016
Download
Suche nach dem Superwirkstoff gegen Krebs
7 May 2016
Download
Eiger BioPharmaceuticals Closes Merger With Celladon Renamed Eiger and New Trading Symbol (NASD: EIGR, as of March 23) Developing a Clinical Stage Pipeline of Orphan Disease Programs
22 March 2016
Download
Skyepharma to merge with Vectura Group
16 March 2016
Download
ARMO BioSciences Raises $50 Million Series C Financing
10 February 2016
Download
Kolltan Pharmaceuticals Provides Update on Clinical Pipeline, Corporate Developments and Near-Term Milestones
8 January 2016
Download
NUVASIVE to aquire Ellipse Technologies
6 January 2016
Download